The introduction of nicotinamide like a nicotine substitute in e-cigarette and smokeless products represents a big regulatory problem to the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is known to act as a sedative at high dosages6. The claims produced by Nicotine River,